Ensign Peak Advisors’s NewAmsterdam Pharma NAMS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-245,571
| Closed | -$4.08M | – | 1721 |
|
|
2024
Q3 | $4.08M | Sell |
245,571
-535
| -0.2% | -$8.88K | 0.01% | 697 |
|
|
2024
Q2 | $4.73M | Hold |
246,106
| – | – | 0.01% | 636 |
|
|
2024
Q1 | $5.82M | Buy |
246,106
+54,150
| +28% | +$1.28M | 0.01% | 587 |
|
|
2023
Q4 | $2.14M | Sell |
191,956
-245,777
| -56% | -$2.75M | ﹤0.01% | 891 |
|
|
2023
Q3 | $4.05M | Sell |
437,733
-4,223
| -1% | -$39.1K | 0.01% | 629 |
|
|
2023
Q2 | $5.25M | Buy |
441,956
+86,956
| +24% | +$1.03M | 0.01% | 570 |
|
|
2023
Q1 | $4.71M | Hold |
355,000
| – | – | 0.01% | 584 |
|
|
2022
Q4 | $3.87M | Buy |
+355,000
| New | +$3.87M | 0.01% | 624 |
|